AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 70.42 |
Market Cap | 41.89B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.59 |
PE Ratio (ttm) | 27.42 |
Forward PE | n/a |
Analyst | Hold |
Ask | 73.79 |
Volume | 2,245,942 |
Avg. Volume (20D) | 4,991,670 |
Open | 71.34 |
Previous Close | 71.09 |
Day's Range | 70.54 - 71.72 |
52-Week Range | 58.93 - 96.12 |
Beta | undefined |
About EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the P...
Analyst Forecast
According to 21 analyst ratings, the average rating for EW stock is "Hold." The 12-month stock price forecast is $78, which is an increase of 9.83% from the latest price.
Next Earnings Release
Analysts project revenue of $1.49B, reflecting a -2.87% YoY shrinking and earnings per share of 0.55, making a -14.06% decrease YoY.